Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines.
We investigated the effect of aphidicolin, an inhibitor of DNA polymerase alpha and delta, on the induction of apoptosis by arabinosyl nucleosides in a human promyelocytic leukemia cell line, HL-60. Pretreatment of HL-60 cells with aphidicolin (2 microM) significantly increased the number of morphologically apoptotic cells induced by 1-beta-D arabinofuranosylcytosine (ara-C) during 4 hr of incubation. This is consistent with the appearance of DNA fragmentation as determined quantitatively by diphenylamine or by agarose gel electrophoresis. The inhibition of cell growth on day 3 after drug exposure was correlated with the degree of apoptosis: Such synergistic interaction between aphidicolin and ara-C has also been observed in other human myeloid leukemia cell lines, U937 and KG-1. In addition, the induction of apoptosis by 9-beta-D arabinofuranosyladenine or 9-beta-D arabinofuranosylguanine is augmented by aphidicolin.
Kuwakado
K
K
Department of Pediatrics, Kyoto University, Japan.
Kubota
M
M
Hirota
H
H
Adachi
S
S
Matsubara
K
K
Kasai
Y
Y
Akiyama
Y
Y
Mikawa
H
H
D016590:Aphidicolin / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001087:Arabinonucleosides / Q000096:biosynthesis / Q000494:pharmacology*; D004247:DNA / Q000378:metabolism; D004357:Drug Synergism; D004587:Electrophoresis, Agar Gel; D006801:Humans; D007951:Leukemia, Myeloid; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014740:Vidarabine / Q000494:pharmacology
D001087:Arabinonucleosides; D016590:Aphidicolin; D004247:DNA; D014740:Vidarabine